The diabetes device market is expected to reach $57.55 billion and counting

𝐆𝐥𝐨𝐛𝐚𝐥 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐞𝐯𝐢𝐜𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐚𝐧𝐝 𝐬𝐡𝐚𝐫𝐞 𝐢𝐬 𝐜𝐮𝐫𝐫𝐞𝐧𝐭𝐥𝐲 𝐯𝐚𝐥𝐮𝐞𝐝 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 𝐔𝐒𝐃. 𝐁𝐞𝐬𝐢𝐝𝐞𝐬, 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐧𝐨𝐭𝐞𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐞𝐱𝐡𝐢𝐛𝐢𝐭𝐬 𝐚 𝐫𝐨𝐛𝐮𝐬𝐭 𝟖 𝟖.% 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐀𝐧𝐧𝐮𝐚𝐥 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐚𝐭𝐞 𝐑𝐚𝐭𝐞 (𝐂𝐀𝐆𝐑) 𝐨𝐯𝐞𝐫 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭𝐞𝐝 𝐭𝐢𝐦𝐞𝐟𝐫𝐚𝐦𝐞 𝐭𝐢𝐦𝐞𝐟𝐫𝐚𝐦𝐞 𝐭𝐢𝐦𝐞𝐟𝐫𝐚𝐦𝐞, 𝟐𝟎𝟐𝟒 – 𝟐𝟎𝟑𝟐 𝟐𝟎𝟑𝟐

𝐕𝐚𝐫𝐢𝐨𝐮𝐬 𝐟𝐚𝐜𝐭𝐨𝐫𝐬 𝐩𝐫𝐨𝐩𝐞𝐥𝐥𝐢𝐧𝐠 𝐭𝐡𝐞 𝐝𝐞 𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:

• The diabetic machines market is mainly driven by the increasing number of people suffering from diabetes across the world. The continuous increase in geriatric population across the globe will also stimulate the market during the forecast period.
• The market is growing lucratively due to increasing device sales in the untapped global market. The market has been waiting for decades for better-conditioned devices that require less time for analysis.

𝐅𝐨𝐫 𝐌𝐨𝐫𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐑𝐞𝐪𝐮𝐞𝐬 𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐬𝐞𝐚 𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭:

https://www.polarismarketresearch.com/industry-analytic/global-diabetes-device-market/request-for-sample

𝐖𝐡𝐚𝐭 𝐀𝐫𝐞 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐞𝐯𝐢𝐜𝐞𝐬?

A diabetes device, commonly known as a “glucometer”, is a medical device that measures the estimated concentration of glucose in the bloodstream. It can also be a strip of glucose paper dipped in a chemical and measured with a glucose chart. It is an essential element of glucose testing, including home blood glucose monitoring (HBGM) in people with diabetes or hypoglycemia. A small drop of blood, taken by gently pricking the fingertip with a lancet, is placed on a disposable test strip, which the glucometer analyzes and based on this determines the level of glucose in the blood. The meter will then display the level in mg/dL or mmol/L.

𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬:

The diabetes device market is highly competitive as each participant wants to create a new device and present it at a competitive price. The most important players operating on the market include:

• Hoffmann-La Roche AG
• Abbott Laboratories Inc.
• Bayer AG
• Johnson & Johnson Inc.
• Medtronic limited liability company
• Sanofi
• Nova Nordisk A/G
• Becton, Dickson and Company

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭:

https://www.polarismarketresearch.com/industry-analytic/global-diabetes-device-market/inquire-before-buying

𝐆𝐫𝐨𝐰𝐭𝐡 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

• Rising prevalence of diabetes: The global rise in diabetes cases, attributed to aging population, sedentary lifestyle and unhealthy diet, is the major factor driving the diabetes devices market. The International Diabetes Federation estimates a significant increase in the number of people with diabetes, requiring effective management solutions.
• Technological advances: Innovations in diabetes management technologies, such as continuous glucose monitoring (CGM) systems, smart insulin pens and closed-loop insulin delivery systems (artificial pancreas), are increasing the accuracy, convenience and effectiveness of diabetes care.
• Increasing awareness and education: Increasing awareness of diabetes and its complications, along with educational initiatives from healthcare organizations and governments, are encouraging more people to regularly monitor their blood glucose levels and proactively manage their condition.
• Favorable reimbursement policies: Supportive reimbursement policies and insurance coverage for diabetes devices in many regions are making these devices more accessible to a wider population, driving market growth

𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

Geographically, North America is expected to dominate the market share during the forecast period as awareness increases regarding the use of various devices as an effective source for diabetes monitoring.
Moreover, the Asia-Pacific region is estimated to witness rapid growth of the diabetes devices market during the forecast period. The main factor influencing the diabetes products industry in the coming years is expected to be the growing number of diabetics.

𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐄𝐧𝐭𝐢𝐫𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑 𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞:

https://www.polarismarketresearch.com/industry-analytic/global-diabetes-device-market

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐁𝐫𝐞𝐚𝐤𝐝𝐨𝐰𝐧:
The market is mainly segmented based on product type and application

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐭𝐲𝐩𝐞 𝐭𝐲𝐩𝐞 𝐭𝐲𝐩𝐞, 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐝𝐞𝐯𝐢𝐜𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐚𝐬:
• Blood glucose monitoring devices
• Self-monitoring glucose meters
• Lancets
• CGMS
• Blood glucose test strips
• Diabetes monitoring software
• Artificial pancreas system
• Insulin delivery device
• Insulin syringes
• Insulin pens
• Insulin pumps

𝐎𝐧 𝐭𝐡𝐞 𝐛𝐚𝐬𝐢𝐬 𝐨𝐟 𝐞𝐧𝐝-𝐮𝐬𝐞 𝐭𝐲𝐩𝐞, 𝐭𝐡𝐞 𝐠𝐥𝐨 𝐛𝐚𝐥 𝐝𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐝𝐞𝐯𝐢𝐜𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐞𝐝 𝐚𝐬:
• Retail pharmacies
• Online pharmacies
• Diabetes clinics
• Others

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐖𝐢𝐝𝐞- 𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐟 𝐏 𝐌𝐑’𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞:

𝐏𝐥𝐚𝐭𝐞𝐥𝐞𝐭 𝐀𝐠𝐠𝐫𝐞𝐠𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫 𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analytic/platelet-aggregation-devices-market

𝐃𝐢𝐚𝐥𝐲𝐬𝐢𝐬 𝐂𝐚𝐭𝐡𝐞𝐭𝐞𝐫𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analytic/dialytic-catheters-market

𝐕𝐢𝐫𝐭𝐮𝐚𝐥 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐓𝐫𝐢𝐚𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analytic/virtual-clinical-trials-market

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐇𝐨𝐥𝐨𝐠𝐫𝐚𝐩𝐡𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: https://www.polarismarketresearch.com/industry-analytics/medical-holography-market

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Polaris market research
Phone: +1-929-297-9727
E-mail: [email protected]

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services to PMR clients across a wide range of enterprises. At Polaris, we are committed to serving PMR’s diverse customer base in the healthcare, technology, semiconductor and chemical industries, as well as a variety of other industries with a global presence. We strive to provide PMR clients with up-to-date information on innovative technologies, rapidly developing markets, emerging business environments and the latest business applications, thus helping them always make informed decisions and seize new opportunities. With a highly competent, experienced and highly skilled team of experts consisting of SMEs, analysts and consultants, at Polaris we strive to deliver value-added business solutions to PMR clients.

This release was published on openPR.